Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Tapentadol - A representative of a new class of MOR-NRI analgesics.

Zajączkowska R, Przewłocka B, Kocot-Kępska M, Mika J, Leppert W, Wordliczek J.

Pharmacol Rep. 2018 Aug;70(4):812-820. doi: 10.1016/j.pharep.2018.01.005. Epub 2018 Jan 31. Review.

PMID:
29921501
2.

Transdermal and Topical Drug Administration in the Treatment of Pain.

Leppert W, Malec-Milewska M, Zajaczkowska R, Wordliczek J.

Molecules. 2018 Mar 17;23(3). pii: E681. doi: 10.3390/molecules23030681. Review.

3.

Analgesic efficacy and safety of epidural oxycodone in patients undergoing total hip arthroplasty: a pilot study.

Olczak B, Kowalski G, Leppert W, Bienert A, Teżyk A, Adamski M, Rzymski S, Wieczorowska-Tobis K.

J Pain Res. 2017 Sep 27;10:2303-2309. doi: 10.2147/JPR.S144799. eCollection 2017.

4.

Oral Prolonged-Release Oxycodone/Naloxone for Managing Pain and Opioid-Induced Constipation: A Review of the Evidence.

Morlion BJ, Mueller-Lissner SA, Vellucci R, Leppert W, Coffin BC, Dickerson SL, O'Brien T.

Pain Pract. 2018 Jun;18(5):647-665. doi: 10.1111/papr.12646. Epub 2017 Nov 28. Review.

PMID:
28944983
5.

A CONSULTATION GUIDE FOR ASSESSING THE APPLICABILITY OF HEALTH TECHNOLOGIES:A CASE STUDY.

Polus S, Pfadenhauer L, Brereton L, Leppert W, Wahlster P, Gerhardus A, Rehfuess E.

Int J Technol Assess Health Care. 2017 Jan;33(5):577-585. doi: 10.1017/S0266462317000745. Epub 2017 Sep 5.

PMID:
28870278
6.

STAKEHOLDER INVOLVEMENT THROUGHOUT HEALTH TECHNOLOGY ASSESSMENT: AN EXAMPLE FROM PALLIATIVE CARE.

Brereton L, Wahlster P, Mozygemba K, Lysdahl KB, Burns J, Polus S, Tummers M, Refolo P, Sacchini D, Leppert W, Chilcott J, Ingleton C, Gardiner C, Goyder E.

Int J Technol Assess Health Care. 2017 Jan;33(5):552-561. doi: 10.1017/S026646231700068X. Epub 2017 Sep 4.

7.

A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.

Nosek K, Leppert W, Nosek H, Wordliczek J, Onichimowski D.

Drug Des Devel Ther. 2017 Aug 22;11:2409-2419. doi: 10.2147/DDDT.S141007. eCollection 2017.

8.

Analgesic efficacy, adverse effects, and safety of oxycodone administered as continuous intravenous infusion in patients after total hip arthroplasty.

Olczak B, Kowalski G, Leppert W, Zaporowska-Stachowiak I, Wieczorowska-Tobis K.

J Pain Res. 2017 May 4;10:1027-1032. doi: 10.2147/JPR.S125449. eCollection 2017.

9.

The role of naloxegol in the management of opioid-induced bowel dysfunction.

Leppert W, Woron J.

Therap Adv Gastroenterol. 2016 Sep;9(5):736-46. doi: 10.1177/1756283X16648869. Epub 2016 May 26. Review.

10.

Nationwide survey on volunteers' training in hospice and palliative care in Poland.

Pawłowski L, Lichodziejewska-Niemierko M, Pawłowska I, Leppert W, Mróz P.

BMJ Support Palliat Care. 2016 Jul 29. pii: bmjspcare-2015-000984. doi: 10.1136/bmjspcare-2015-000984. [Epub ahead of print]

PMID:
27474087
11.

Lay and professional stakeholder involvement in scoping palliative care issues: Methods used in seven European countries.

Brereton L, Ingleton C, Gardiner C, Goyder E, Mozygemba K, Lysdahl KB, Tummers M, Sacchini D, Leppert W, Blaževičienė A, van der Wilt GJ, Refolo P, De Nicola M, Chilcott J, Oortwijn W.

Palliat Med. 2017 Feb;31(2):181-192. doi: 10.1177/0269216316649154. Epub 2016 Jul 10.

12.

Clinical practice recommendations for quality of life assessment in patients with gynecological cancer.

Leppert W, Gottwald L, Forycka M.

Prz Menopauzalny. 2015 Dec;14(4):271-82. doi: 10.5114/pm.2015.56539. Epub 2015 Dec 22. Review.

13.

Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain.

Leppert W, Kowalski G.

Onco Targets Ther. 2015 Dec 4;8:3621-7. doi: 10.2147/OTT.S91347. eCollection 2015.

14.

Identification of the palliative phase in people with dementia: a variety of opinions between healthcare professionals.

van Riet Paap J, Mariani E, Chattat R, Koopmans R, Kerhervé H, Leppert W, Forycka M, Radbruch L, Jaspers B, Vissers K, Vernooij-Dassen M, Engels Y; IMPACT research team.

BMC Palliat Care. 2015 Nov 4;14:56. doi: 10.1186/s12904-015-0053-8.

15.

Dihydrocodeine: safety concerns.

Leppert W, Woroń J.

Expert Rev Clin Pharmacol. 2016;9(1):9-12. doi: 10.1586/17512433.2016.1092871. Epub 2015 Oct 19.

PMID:
26479786
16.

Implementation of improvement strategies in palliative care: an integrative review.

van Riet Paap J, Vernooij-Dassen M, Sommerbakk R, Moyle W, Hjermstad MJ, Leppert W, Vissers K, Engels Y; IMPACT research team.

Implement Sci. 2015 Jul 26;10:103. doi: 10.1186/s13012-015-0293-2. Review.

17.

Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction.

Leppert W.

Drug Des Devel Ther. 2015 Apr 16;9:2215-31. doi: 10.2147/DDDT.S32684. eCollection 2015. Review.

18.

Improving the organization of palliative care: identification of barriers and facilitators in five European countries.

van Riet Paap J, Vernooij-Dassen M, Brouwer F, Meiland F, Iliffe S, Davies N, Leppert W, Jaspers B, Mariani E, Sommerbakk R, Vissers K, Engels Y; IMPACT research team.

Implement Sci. 2014 Oct 16;9:130. doi: 10.1186/s13012-014-0130-z.

19.

Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish Association for the Study of Pain and the Polish Neurological Society - Part Two.

Szczudlik A, Dobrogowski J, Wordliczek J, Stępień A, Krajnik M, Leppert W, Woroń J, Przeklasa-Muszyńska A, Kocot-Kępska M, Zajączkowska R, Janecki M, Adamczyk A, Malec-Milewska M.

Neurol Neurochir Pol. 2014;48(6):423-35. doi: 10.1016/j.pjnns.2014.11.002. Epub 2014 Nov 16. Review.

PMID:
25482254
20.

Analgesic effects of morphine in combination with adjuvant drugs in rats.

Leppert W, Okulicz-Kozaryn I, Kaminska E, Szulc M, Mikolajczak P.

Pharmacology. 2014;94(5-6):207-13. doi: 10.1159/000365220. Epub 2014 Nov 8.

PMID:
25402013

Supplemental Content

Loading ...
Support Center